Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2-Reference-Cited by-同舟云学术

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

Published:2021-04 Issue:1 Volume:35 Page:108959
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Dittmar Mark^ORCID,Lee Jae Seung,Whig Kanupriya,Segrist Elisha,Li Minghua^ORCID,Kamalia Brinda,Castellana Lauren,Ayyanathan Kasirajan,Cardenas-Diaz Fabian L.,Morrisey Edward E.,Truitt Rachel,Yang Wenli,Jurado Kellie,Samby Kirandeep,Ramage Holly^ORCID,Schultz David C.,Cherry Sara

Funder

National Institutes of Health

Burroughs Wellcome Fund

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference115 articles.

1. Drug repositioning: identifying and developing new uses for existing drugs;Ashburn;Nat. Rev. Drug Discov.,2004

2. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications;Bailly;Phytomedicine,2019

3. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply;Beigel;N. Engl. J. Med.,2020

4. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites;Belouzard;Proc. Natl. Acad. Sci. USA,2009

5. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19;Blanco-Melo;Cell,2020

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polarised human alveolar epithelia enable identification of dichloroacetate as an effective drug against respiratory viruses;2024-09-05

2. Effect of cyclosporin A on respiratory viral replication in fully differentiated ex vivo human airway epithelia;Pharmacology Research & Perspectives;2024-08-29

3. An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease;Microbiology Spectrum;2024-08-20

4. The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2;mBio;2024-08-14

5. PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies;Clinical and Translational Science;2024-07